OpenURL Connection Search

Select item for more details and to access through your institution.

CARDIOVASCULAR EFFECTS OF NEUROMUSCULAR BLOCKADE DURING INDUCED HYPOTHERMIA.
Published in:
Clinical & Experimental Pharmacology & Physiology, 1984, v. 11, n. 2, p. 181, doi. 10.1111/j.1440-1681.1984.tb00255.x
By:
- Wyse, Richard K. H.;
- Silove, Eric D.;
- Godley, Margaret L.;
- Welham, Kenneth C.
Publication type:
Article
Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experience.
Published in:
Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.653377
By:
- Stott, Simon R. W.;
- Wyse, Richard K.;
- Brundin, Patrik
Publication type:
Article
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
Published in:
JAMA Neurology, 2021, v. 78, n. 3, p. 312, doi. 10.1001/jamaneurol.2020.4725
By:
- Simuni, Tanya;
- Fiske, Brian;
- Merchant, Kalpana;
- Coffey, Christopher S.;
- Klingner, Elizabeth;
- Caspell-Garcia, Chelsea;
- Lafontant, David-Erick;
- Matthews, Helen;
- Wyse, Richard K.;
- Brundin, Patrik;
- Simon, David K.;
- Schwarzschild, Michael;
- Weiner, David;
- Adams, Jamie;
- Venuto, Charles;
- Dawson, Ted M.;
- Baker, Liana;
- Kostrzebski, Melissa;
- Ward, Tina;
- Rafaloff, Gary
Publication type:
Article
The Linked Clinical Trials initiative (LCT) for Parkinson's disease.
Published in:
European Journal of Neuroscience, 2019, v. 49, n. 3, p. 307, doi. 10.1111/ejn.14175
By:
- Brundin, Patrik;
- Wyse, Richard K.
Publication type:
Article
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.
Published in:
PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0309893
By:
- Minnella, Angela;
- McCusker, Kevin P.;
- Amagata, Akiko;
- Trias, Beatrice;
- Weetall, Marla;
- Latham, Joey C.;
- O'Neill, Sloane;
- Wyse, Richard K.;
- Klein, Matthew B.;
- Trimmer, Jeffrey K.
Publication type:
Article
Cellular and molecular aspects of Goodpasture syndrome.
Published in:
2012
By:
- Alenzi FQ;
- Salem ML;
- Alenazi FA;
- Wyse RK;
- Alenzi, Faris Q;
- Salem, Mohamed L;
- Alenazi, Fawwaz A;
- Wyse, Richard K
Publication type:
journal article
Cellular and Molecular Aspects of Goodpasture Syndrome.
Published in:
Iranian Journal of Kidney Diseases, 2012, v. 6, n. 1, p. 1
By:
- Alenzi, Faris Q;
- Salem, Mohammed L.;
- Alenazi, Fawwaz A.;
- Wyse, Richard K.
Publication type:
Article
Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease.
Published in:
Movement Disorders, 2022, v. 37, n. 2, p. 334, doi. 10.1002/mds.28850
By:
- Surmeier, D. James;
- Nguyen, Jack T.;
- Lancki, Nicola;
- Venuto, Charles S.;
- Oakes, David;
- Simuni, Tanya;
- Wyse, Richard K.
Publication type:
Article
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD).
Published in:
Frontiers in Aging Neuroscience, 2024, p. 1, doi. 10.3389/fnagi.2024.1308577
By:
- Wolff, Andreas W.;
- Bidner, Helen;
- Remane, Yvonne;
- Zimmer, Janine;
- Aarsland, Dag;
- Rascol, Olivier;
- Wyse, Richard K.;
- Hapfelmeier, Alexander;
- Lingor, Paul
Publication type:
Article

Found: 9